Case | HBS Case Collection | 2012
by Toby Stuart and James Weber
Describes a set of key strategic decisions facing the scientific founder and CEO of a promising, early stage bio-pharmaceuticals company. Should the company establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate?
Keywords: Business Startups; Decision Choices and Conditions; Entrepreneurship; Growth and Development Strategy; Risk Management; Brands and Branding; Pharmaceutical Industry;
Citation:
Stuart, Toby, and James Weber. "Sirtris Pharmaceuticals: Living Healthier, Longer (Abridged)." Harvard Business School Case 813-029, October 2012.
Case | HBS Case Collection | 2013 (Revised from original 2013 version)
OrganJet and GuardianWings
Julie Battilana and James Weber
Case | HBS Case Collection | 2013 (Revised from original 2010 version)
Gazelle in 2012
Andrei Hagiu and James Weber
Keywords: Business Model; Growth and Development Strategy; Markets; Two-Sided Platforms; Partners and Partnerships; Business Strategy; Retail Industry; Service Industry;
Case | HBS Case Collection | 2013
Elasto Therm: The Next Step
Jim Sharpe and James Weber
Keywords: entrepreneurial management; entrepreneurs; entrepreneurship; pricing; Pricing policies; Pricing strategy; pricing structure; sales force management; Acquisitions; work/family balance; work-life balance; Family-owned business; Entrepreneurship; Growth and Development Strategy; Expansion; Work-Life Balance; Manufacturing Industry; Rubber Industry; United States;